Switch theme
Sign up to access all valuation multiples
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore.
1999
669
LTM Revenue $271M
LTM EBITDA $79.1M
$1.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Thomson Medical has a last 12-month revenue (LTM) of $271M and a last 12-month EBITDA of $79.1M.
In the most recent fiscal year, Thomson Medical achieved revenue of $271M and an EBITDA of $84.7M.
Thomson Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Thomson Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $271M | XXX | $271M | XXX | XXX | XXX |
| Gross Profit | $271M | XXX | $213M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 79% | XXX | XXX | XXX |
| EBITDA | $79.1M | XXX | $84.7M | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 31% | XXX | XXX | XXX |
| EBIT | $57.9M | XXX | $37.8M | XXX | XXX | XXX |
| EBIT Margin | 21% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $11.9M | XXX | $11.9M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $726M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Thomson Medical's stock price is SGD 0 (or $0).
Thomson Medical has current market cap of SGD 1.1B (or $879M), and EV of SGD 2.1B (or $1.6B).
See Thomson Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.6B | $879M | XXX | XXX | XXX | XXX | $0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Thomson Medical has market cap of $879M and EV of $1.6B.
Thomson Medical's trades at 6.0x EV/Revenue multiple, and 19.5x EV/EBITDA.
Equity research analysts estimate Thomson Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Thomson Medical has a P/E ratio of 73.7x.
See valuation multiples for Thomson Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $879M | XXX | $879M | XXX | XXX | XXX |
| EV (current) | $1.6B | XXX | $1.6B | XXX | XXX | XXX |
| EV/Revenue | 6.0x | XXX | 6.0x | XXX | XXX | XXX |
| EV/EBITDA | 20.6x | XXX | 19.5x | XXX | XXX | XXX |
| EV/EBIT | 28.2x | XXX | 32.3x | XXX | XXX | XXX |
| EV/Gross Profit | 6.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | 73.7x | XXX | 43.7x | XXX | XXX | XXX |
| EV/FCF | 37.4x | XXX | 32.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialThomson Medical's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.
Thomson Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Thomson Medical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Thomson Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 65% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Thomson Medical acquired XXX companies to date.
Last acquisition by Thomson Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Thomson Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Thomson Medical founded? | Thomson Medical was founded in 1999. |
| Where is Thomson Medical headquartered? | Thomson Medical is headquartered in Singapore. |
| How many employees does Thomson Medical have? | As of today, Thomson Medical has 669 employees. |
| Is Thomson Medical publicy listed? | Yes, Thomson Medical is a public company listed on SES. |
| What is the stock symbol of Thomson Medical? | Thomson Medical trades under A50 ticker. |
| When did Thomson Medical go public? | Thomson Medical went public in 2002. |
| Who are competitors of Thomson Medical? | Similar companies to Thomson Medical include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Thomson Medical? | Thomson Medical's current market cap is $879M |
| What is the current revenue of Thomson Medical? | Thomson Medical's last 12 months revenue is $271M. |
| What is the current EV/Revenue multiple of Thomson Medical? | Current revenue multiple of Thomson Medical is 6.0x. |
| Is Thomson Medical profitable? | Yes, Thomson Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Thomson Medical? | Thomson Medical's last 12 months EBITDA is $79.1M. |
| What is Thomson Medical's EBITDA margin? | Thomson Medical's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of Thomson Medical? | Current EBITDA multiple of Thomson Medical is 20.6x. |
| What is the current FCF of Thomson Medical? | Thomson Medical's last 12 months FCF is $43.7M. |
| What is Thomson Medical's FCF margin? | Thomson Medical's last 12 months FCF margin is 16%. |
| What is the current EV/FCF multiple of Thomson Medical? | Current FCF multiple of Thomson Medical is 37.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
